MIR7151

Across TCGA pan-cancer cohorts, MIR7151 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR7151 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher MIR7151 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR7151 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

ESCA, KIRC, and LAML are the cancer types where MIR7151 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Tertile	III,IV	1.000	0.269	.015	42	view →
KIRC	DFS	Tertile	All	0.198	0.796	.005	18	view →
LAML	DFS	Tertile	All	0.056	0.572	.001	18	view →
STAD	OS	Tertile	III,IV	0.154	0.502	.032	9	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

MIR7151–ESCA (DFS)

Open the ESCA breakdown →